Hyperosmolarity-mediated mitochondrial dysfunction requires Transglutaminase-2 in human Corneal epithelial cells

Journal of Cellular Physiology

Volumn 226, Issue 3, 2011, Pages 693-699

  Png, Evelyn ^a   Samivelu, G K ^a   Yeo, S H ^a   Chew, J ^a   Chaurasia, Shyam S ^a   Tong, Louis ^a,b  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b SINGAPORE NATIONAL EYE CENTRE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 9; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; SHORT HAIRPIN RNA;

APOPTOSIS; ARTICLE; CORNEA ENDOTHELIUM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYPEROSMOLARITY; MEMBRANE DEPOLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL PROLIFERATION; CELLS, CULTURED; EPITHELIAL CELLS; EPITHELIUM, CORNEAL; FLUORESCENCE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MODELS, BIOLOGICAL; OSMOLAR CONCENTRATION; TRANSGLUTAMINASES;

EID: 78650642603     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22389     Document Type: Article

References (49)

1. Antonyak MA, Singh US, Lee DA, Boehm JE, Combs C, Zgola MM, Page RL, Cerione RA. 2001. Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis. J Biol Chem 276: 33582-33587.
2. Araki-Sasaki K, Ohashi Y, Sasabe T, Hayashi K, Watanabe H, Tano Y, Handa H. 1995. An SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci 36: 614-621.
3. Bron AJ, Yokoi N, Gafney E, Tiffany JM. 2009. Predicted phenotypes of dry eye: Proposed consequences of its natural history. Ocul Surf 7: 78-92.
4. Chen JS, Mehta K. 1999. Tissue transglutaminase: An enzyme with a split personality. Int J Biochem Cell Biol 31: 817-836.
5. Chen JS, Konopleva M, Andreeff M, Multani AS, Pathak S, Mehta K. 2004. Drug-resistant breast carcinoma (MCF-7) cells are paradoxically sensitive to apoptosis. J Cell Physiol 200: 223-234.
6. Chen Z, Tong L, Li Z, Yoon KC, Qi H, Farley W, Li DQ, Pflugfelder SC. 2008. Hyperosmolarity-induced cornification of human corneal epithelial cells is regulated by JNK MAPK. Invest Ophthalmol Vis Sci 49: 539-549.
7. Elli L, Bergamini CM, Bardella MT, Schuppan D. 2009. Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver. Dig Liver Dis 41: 541-550.
8. Fesus L, Thomazy V, Falus A. 1987. Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett 224: 104-108.
9. Foulks GN. 2007. The correlation between the tear film lipid layer and dry eye disease. Surv Ophthalmol 52: 369-374.
10. Gentile V, Thomazy V, Piacentini M, Fesus L, Davies PJ. 1992. Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: Effects on cellular morphology and adhesion. J Cell Biol 119: 463-474.
11. Gumus K, Cavanagh DH. 2009. The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca. Clin Ophthalmol 3: 57-67.
12. Hashimoto S, Matsumoto K, Gon Y, Nakayama T, Takeshita I, Horie T. 1999. Hyperosmolarity-induced interleukin-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase. Am J Respir Crit Care Med 159: 634-640.
13. Hazlett LD. 2007. Bacterial infections of the cornea (Pseudomonas aeruginosa). Chem Immunol Allergy 92: 185-194.
14. Kimura K, Teranishi S, Fukuda K, Kawamoto K, Nishida T. 2008. Delayed disruption of barrier function in cultured human corneal epithelial cells induced by tumor necrosis factor-alpha in a manner dependent on NF-kappaB. Invest Ophthalmol Vis Sci 49: 565-571.
15. Krasnikov BF, Kim SY, McConoughey SJ, Ryu H, Xu H, Stavrovskaya I, Iismaa SE, Mearns BM, Ratan RR, Blass JP, Gibson GE, Cooper AJ. 2005. Transglutaminase activity is present in highly purified nonsynaptosomal mouse brain and liver mitochondria. Biochemistry 44: 7830-7843.
16. Lambiase A, Micera A, Pellegrini G, Merlo D, Rama P, De Luca M, Bonini S. 2009. In vitro evidence of nerve growth factor effects on human conjunctival epithelial cell differentiation and mucin gene expression. Invest Ophthalmol Vis Sci 50: 4622-4630.
17. Lawrenson JG, Murphy PJ, Esmaeelpour M. 2003. The neonatal tear film. Cont Lens Anterior Eye 26: 197-202.
18. Lim W, Kim JH, Gook E, Kim J, Ko Y, Kim I, Kwon H, Lim H, Jung B, Yang K, Choi N, Kim M, Kim S, Choi H, Kim O. 2009. Inhibition of mitochondria-dependent apoptosis by 635-nm irradiation in sodium nitroprusside-treated SH-SY5Y cells. Free Radic Biol Med 47: 850-857.
19. Liu S, Cerione RA, Clardy J. 2002. Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity. Proc Natl Acad Sci USA 99: 2743-2747.
20. Luo L, Li DQ, Pflugfelder SC. 2004. Hyperosmolarity induces apoptosis through a cytochrome c-mediated death pathway and MAPK activation in human corneal epithelial cells. Invest Ophthalmol Vis Sci 45: E-Abstract: 3758.
21. Luo L, Li DQ, Corrales RM, Pflugfelder SC. 2005. Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. Eye Contact Lens 31: 186-193.
22. Mangiameli DP, Blansfield JA, Kachala S, Lorang D, Schafer PH, Muller GW, Stirling DI, Libutti SK. 2007. Combination therapy targeting the tumor microenvironment is effective in a model of human ocular melanoma. J Transl Med 5: 38.
23. Mastroberardino PG, Farrace MG, Viti I, Pavone F, Fimia GM, Melino G, Rodolfo C, Piacentini M. 2006. " Tissue" transglutaminase contributes to the formation of disulphide bridges in proteins of mitochondrial respiratory complexes. Biochim Biophys Acta 1757: 1357-1365.
24. Murthy SN, Lomasney JW, Mak EC, Lorand L. 1999. Interactions of G(h)/transglutaminase with phospholipase Cdelta1 and with GTP. Proc Natl Acad Sci USA 96: 11815-11819.
25. Niizuma K, Endo H, Chan PH. 2009. Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J Neurochem 109: 133-138.
26. Niswander JM, Dokas LA. 2007. Hyperosmotic stress-induced caspase-3 activation is mediated by p38 MAPK in the hippocampus. Brain Res 1186: 1-11.
27. Peng X, Zhang Y, Zhang H, Graner S, Williams JF, Levitt ML, Lokshin A. 1999. Interaction of tissue transglutaminase with nuclear transport protein importin-alpha3. FEBS Lett 446: 35-39.
28. Pflugfelder SC, Solomon A, Dursun D, Li DQ. 2002. Dry eye and delayed tear clearance: "A call to arms.". Adv Exp Med Biol 506: 739-743.
29. Pflugfelder SC, de Paiva CS, Li DQ, Stern ME. 2008. Epithelial-immune cell interaction in dry eye. Cornea 27: S9-S11.
30. Piacentini M, Farrace MG, Piredda L, Matarrese P, Ciccosanti F, Falasca L, Rodolfo C, Giammarioli AM, Verderio E, Griffin M, Malorni W. 2002. Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress. J Neurochem 81: 1061-1072.
31. Rieger G. 1992. The importance of the precorneal tear film for the quality of optical imaging. Br J Ophthalmol 76: 157-158.
32. Rodolfo C, Mormone E, Matarrese P, Ciccosanti F, Farrace MG, Garofano E, Piredda L, Fimia GM, Malorni W, Piacentini M. 2004. Tissue transglutaminase is a multifunctional BH3-only protein. J Biol Chem 279: 54783-54792.
33. Shapiro L, Dinarello CA. 1997. Hyperosmotic stress as a stimulant for proinflammatory cytokine production. Exp Cell Res 231: 354-362.
34. Shin DM, Jeon JH, Kim CW, Cho SY, Kwon JC, Lee HJ, Choi KH, Park SC, Kim IG. 2004. Cell type-specific activation of intracellular transglutaminase 2 by oxidative stress or ultraviolet irradiation: Implications of transglutaminase 2 in age-related cataractogenesis. J Biol Chem 279: 15032-15039.
35. Shin DM, Jeon JH, Kim CW, Cho SY, Lee HJ, Jang GY, Jeong EM, Lee DS, Kang JH, Melino G, Park SC, Kim IG. 2008. TGFbeta mediates activation of transglutaminase 2 in response to oxidative stress that leads to protein aggregation. FASEB J 22: 2498-2507.
36. Siegel M, Khosla C. 2007. Transglutaminase 2 inhibitors and their therapeutic role in disease states. Pharmacol Ther 115: 232-245.
37. Szegezdi E, Macdonald DC, Ni Chonghaile T, Gupta S, Samali A. 2009. Bcl-2 family on guard at the ER. Am J Physiol Cell Physiol 296: C941-C953.
38. Szondy Z, Mastroberardino PG, Varadi J, Farrace MG, Nagy N, Bak I, Viti I, Wieckowski MR, Melino G, Rizzuto R, Tosaki A, Fesus L, Piacentini M. 2006. Tissue transglutaminase (TG2) protects cardiomyocytes against ischemia/reperfusion injury by regulating ATP synthesis. Cell Death Differ 13: 1827-1829.
39. Tatsukawa H, Fukaya Y, Frampton G, Martinez-Fuentes A, Suzuki K, Kuo TF, Nagatsuma K, Shimokado K, Okuno M, Wu J, Iismaa S, Matsuura T, Tsukamoto H, Zern MA, Graham RM, Kojima S. 2009. Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1. Gastroenterology 136: 1783-1795. e1710.
40. Tharakan B, Holder-Haynes JG, Hunter FA, Smythe WR, Childs EW. 2009. Cyclosporine A prevents vascular hyperpermeability after hemorrhagic shock by inhibiting apoptotic signaling. J Trauma 66: 1033-1039.
41. Thomas ML, Szeto VR, Gan CM, Polse KA. 1997. Sequential staining: The effects of sodium fluorescein, osmolarity, and pH on human corneal epithelium. Optom Vis Sci 74: 207-210.
42. Tomlinson A, Khanal S, Ramaesh K, Diaper C, McFadyen A. 2006. Tear film osmolarity: Determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci 47: 4309-4315.
43. Tong L, Chen Z, De Paiva CS, Beuerman R, Li DQ, Pflugfelder SC. 2006. Transglutaminase participates in UVB-induced cell death pathways in human corneal epithelial cells. Invest Ophthalmol Vis Sci 47: 4295-4301.
44. Tong L, Li J, Chew J, Tan D, Beuerman R. 2008. Phospholipase D in the human ocular surface and in pterygium. Cornea 27: 693-698.
45. Tovar-Vidales T, Roque R, Clark AF, Wordinger RJ. 2008. Tissue transglutaminase expression and activity in normal and glaucomatous human trabecular meshwork cells and tissues. Invest Ophthalmol Vis Sci 49: 622-628.
46. Virag L, Szabo C. 2000. BCL-2 protects peroxynitrite-treated thymocytes from poly(ADP-ribose) synthase (PARS)-independent apoptotic but not from PARS-mediated necrotic cell death. Free Radic Biol Med 29: 704-713.
47. Wang YH, Ho ML, Chang JK, Chu HC, Lai SC, Wang GJ. 2009. Microporation is a valuable transfection method for gene expression in human adipose tissue-derived stem cells. Mol Ther 17: 302-308.
48. Yang PM, Chen HC, Tsai JS, Lin LY. 2007. Cadmium induces Ca2+-dependent necrotic cell death through calpain-triggered mitochondrial depolarization and reactive oxygen species-mediated inhibition of nuclear factor-kappaB activity. Chem Res Toxicol 20: 406-415.
49. Zelenka PS, Arpitha P. 2008. Coordinating cell proliferation and migration in the lens and cornea. Semin Cell Dev Biol 19: 113-124.